We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$342B
AUM Growth
+$4.99B
Cap. Flow
-$5.86B
Cap. Flow %
-1.71%
Top 10 Hldgs %
31.71%
Holding
3,487
New
211
Increased
1,344
Reduced
1,316
Closed
159

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.03B
2
VLO icon
Valero Energy
VLO
+$273M
3
PGR icon
Progressive
PGR
+$259M
4
AMD icon
Advanced Micro Devices
AMD
+$256M
5
ORLY icon
O'Reilly Automotive
ORLY
+$232M

Sector Composition

Rank Sector Weight
1 Technology 31.78%
2 Financials 11.71%
3 Healthcare 11.09%
4 Consumer Discretionary 10.64%
5 Communication Services 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGLS icon
2176
Tecnoglass Holdings Inc.
TGLS
$1.96B
$2.87M ﹤0.01%
+57,250
New +$2.99M
PEBO icon
2177
Peoples Bancorp
PEBO
$1.47B
$2.87M ﹤0.01%
95,584
+2,935
+3% +$85.2K
SBH icon
2178
Sally Beauty Holdings
SBH
$1.58B
$2.86M ﹤0.01%
266,633
+19,170
+8% +$211K
OCUL icon
2179
Ocular Therapeutix
OCUL
$2.02B
$2.85M ﹤0.01%
416,773
-796,672
-66% -$4.92M
NIC icon
2180
Nicolet Bankshares
NIC
$3.62B
$2.85M ﹤0.01%
34,310
+1,749
+5% +$140K
PRM icon
2181
Perimeter Solutions
PRM
$5.77B
$2.84M ﹤0.01%
363,084
PRA
2182
DELISTED
ProAssurance
PRA
$2.84M ﹤0.01%
232,218
+2,614
+1% +$35.5K
PLYM
2183
DELISTED
Plymouth Industrial REIT
PLYM
$2.82M ﹤0.01%
131,870
-40,610
-24% -$851K
UVE icon
2184
Universal Insurance Holdings
UVE
$1.23B
$2.81M ﹤0.01%
149,912
AMRC icon
2185
Ameresco
AMRC
$1.36B
$2.8M ﹤0.01%
97,344
-634
-0.6% -$17.5K
CLB icon
2186
Core Laboratories
CLB
$521M
$2.8M ﹤0.01%
137,841
SAFT icon
2187
Safety Insurance
SAFT
$1.52B
$2.79M ﹤0.01%
37,228
+1,029
+3% +$80.8K
PENG
2188
Penguin Solutions Inc
PENG
$2.99B
$2.78M ﹤0.01%
121,476
-889,059
-88% -$18.5M
PRAA icon
2189
PRA Group
PRAA
$755M
$2.77M ﹤0.01%
141,148
+20,791
+17% +$478K
ERAS icon
2190
Erasca
ERAS
$6.39B
$2.77M ﹤0.01%
1,172,606
+482,405
+70% +$1.04M
SYRE icon
2191
Spyre Therapeutics
SYRE
$9.25B
$2.75M ﹤0.01%
+117,140
New +$3.95M
DCO icon
2192
Ducommun
DCO
$2.98B
$2.74M ﹤0.01%
47,235
+13,430
+40% +$750K
MRVI icon
2193
Maravai LifeSciences
MRVI
$919M
$2.74M ﹤0.01%
382,679
+185,000
+94% +$1.6M
HE icon
2194
Hawaiian Electric Industries
HE
$2.14B
$2.74M ﹤0.01%
303,617
+255,650
+533% +$2.66M
LESL icon
2195
Leslie's
LESL
$11M
$2.73M ﹤0.01%
32,578
-57
-0.2% -$5.54K
TIPT icon
2196
Tiptree Inc
TIPT
$675M
$2.73M ﹤0.01%
165,533
+56,580
+52% +$946K
HIBB
2197
DELISTED
Hibbett, Inc. Common Stock
HIBB
$2.73M ﹤0.01%
31,280
-9,038
-22% -$748K
SOC icon
2198
Sable Offshore Corp
SOC
$911M
$2.72M ﹤0.01%
+180,298
New +$2.27M
RVNC
2199
DELISTED
Revance Therapeutics, Inc.
RVNC
$2.71M ﹤0.01%
1,056,062
+704,020
+200% +$2.4M
ATXS
2200
DELISTED
Astria Therapeutics
ATXS
$2.71M ﹤0.01%
298,037
+90,840
+44% +$887K

Similar funds

Nuveen's Q2 2024 Portfolio in Review

As of Q2 2024, Nuveen held 3,487 positions worth $342B, up 1.5% from $337B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Nuveen's Q2 2024 filing shows 211 new, 1,344 increased, 1,316 reduced and 159 closed positions. Its largest new stake was GE Vernova: 595,802 shares worth $102M. The largest sale was Meta Platforms (Facebook), an estimated $466M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q2 2024 buy was GE Vernova: 595,802 shares worth $102M.
  • Nuveen added most to Apple in Q2 2024, an estimated $1.03B increase.
  • Nuveen's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $466M.
  • Nuveen fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $389M.
  • Nuveen's ten largest holdings make up 32% of its $342B portfolio in Q2 2024.
  • Nuveen opened 211 new positions and closed 159 in Q2 2024.
  • Nuveen's portfolio value rose 1.5% quarter-over-quarter to $342B.

Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.